ZBTB43
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
9129575594rs7856497AGrs78564970.0008821INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN GTUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTORAnti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)HPOID:0001370DOID:7148GintronGWASdb_drug
9129575594rs7856497AGrs78564978.82E-04LEUCOVORIN|METHOTREXATESLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERSMethotrexate clearance (acute lymphoblastic leukemia)HPOID:0006721DOID:9952|DOID:12603GintronGWASdb_drug
9129580187rs516104AGrs5161040.0008819INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN GTUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTORAnti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)HPOID:0001370DOID:7148GintronGWASdb_drug
9129580187rs516104AGrs5161048.82E-04LEUCOVORIN|METHOTREXATESLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERSMethotrexate clearance (acute lymphoblastic leukemia)HPOID:0006721DOID:9952|DOID:12603GintronGWASdb_drug
9129575594rs7856497AGrs78564970.0008821Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)HPOID:0001370DOID:7148GintronGWASdb_trait
9129575594rs7856497AGrs78564978.82E-04Methotrexate clearance (acute lymphoblastic leukemia)HPOID:0006721DOID:9952|DOID:12603GintronGWASdb_trait
9129580187rs516104AGrs5161040.0008819Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)HPOID:0001370DOID:7148GintronGWASdb_trait
9129580187rs516104AGrs5161048.82E-04Methotrexate clearance (acute lymphoblastic leukemia)HPOID:0006721DOID:9952|DOID:12603GintronGWASdb_trait